Drugs / DENSPM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00081900 | Mar 2004 → Jul 2007 | hepatocellular carcinoma | Genzyme, a Sanofi Company | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DENSPM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00081900 ↗ |
| Route | Intravenous | “single IV infusion” NCT00081900 ↗ |